Archive for March, 2012

• 

  Invest in our work and help us save lives!

• Archives

  • April 2013 (7)
  • March 2013 (5)
  • February 2013 (1)
  • January 2013 (3)
  • December 2012 (1)
  • November 2012 (4)
  • October 2012 (1)
  • July 2012 (1)
  • June 2012 (3)
  • May 2012 (1)
  • April 2012 (2)
  • March 2012 (3)
  • February 2012 (2)
  • January 2012 (1)
  • December 2011 (2)
  • November 2011 (3)
  • October 2011 (1)
  • September 2011 (1)
  • August 2011 (1)
  • June 2011 (3)
  • April 2011 (1)

• Categories

  • Clinical Trials
  • Diarrheal Diseases
  • Events
  • Global Health R&D Advocacy
  • Japanese Encephalitis
  • Kala-Azar
  • Malaria
  • OWH General
  • Polio
  • Treatment
  • Uncategorized

• Follow us on Twitter

  • @WHO approval of #ssART "represents many years of hard work by the team & our colleagues" who met "high quality expectations." Nina Grove 1 day ago
  • .@GHTCoalition details obstacles in R&D for neglected diseases and offers solutions. bit.ly/10uqevx #globalhealth 1 day ago
  • .@WHO approval caps "9 yrs of scientific breakthrough" & “exemplifies role of PDPs in solving impt public health challenges." Dr. Tue Nguyen 2 days ago
  • #BillGates congratulates ssART team at #WorldMalariaDay event hosted by @UCBerkeley & @zagayateam. bit.ly/YJDKuC 3 days ago
  • Prequalification from @WHO for manufacturing w ssART will increase access to vital antimalarials. bit.ly/16xAlnu 3 days ago

• Follow us on Facebook